Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: Example of coronary artery bypass surgery

Emerging Infectious Diseases

Volumn 7, Issue 5, 2001, Pages 820-827

  Zanetti, Giorgio ^a,b   Goldie, Sue J ^c   Platt, Richard ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CORONARY ARTERY BYPASS SURGERY; COST BENEFIT ANALYSIS; DRUG CHOICE; DRUG COST; HEALTH CARE COST; MEDICAL DECISION MAKING; MORTALITY; PERIOPERATIVE PERIOD; SURGICAL INFECTION;

EID: 0035203552     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0705.010508     Document Type: Article

References (43)

1. New resistance in Staphylococcus aureus
2. Emergence of vancomycin resistance in Staphylococcus aureus
3. Epidemiology, appropriateness, and cost of vancomycin use
4. Spread of vancomycin-resistant enterococci: Why did it happen in the United States?
5. Recommendations for preventing the spread of vancomycin resistance Recommendations of the Hospital Infection Control Practices Advisory Committee
6. Current guidelines for antibiotic prophylaxis of surgical wounds
7. Quality standard for antimicrobial prophylaxis in surgical procedures
8. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care
9. Antimicrobial prophylaxis in surgery
10. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery
11. Antimicrobial prophylaxis in surgery: General concepts and clinical guidelines
12. The epidemiology of chest and leg wound infections following cardiothoracic surgery
13. Coagulase-negative staphylococcal sternal wound infections after open heart operations
14. Diagnosis of suspected coronary artery disease in women: A cost-effectiveness analysis
15. Twenty-two year follow-up in the VA cooperative study of coronary artery bypass surgery for stable angina
16. A multi-institutional comparison of surgical site infection surveillance by screening of administrative and pharmacy data
17. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery
18. Antibiotic prophylaxis in vascular surgery
19. Prophylaxis against wound infection following herniorrhaphy or breast surgery
20. Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection
21. Perioperative antibiotic prophylaxis and wound infection following breast surgery
22. Antibiotic prophylaxis of wound infections in skin surgery
23. A pharmacoeconomic model to evaluate antibiotic costs
24. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations
25. Allergy to penicillin and other antibiotics
26. Nature and extent of penicillin side reactions with particular reference to fatalities from anaphylactic shock
27. Statewide quality improvement initiatives and mortality after cardiac surgery
28. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery
29. Total and attributable costs of surgical-wound infections at a canadian tertiary-care center
30. Hospital cost of complications associated with coronary artery bypass graft surgery
31. The economic impact of Staphylococcus aureus infection in New York City hospitals
32. Antibiotic prophylaxis for coronary artery bypass graft surgery
33. The value of prophylactic antibiotics in aorto-coronary bypass operations: A double-blind randomized trial
34. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement
35. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery
36. The Beaver Dam health outcomes study: Initial catalog of health-state quality factors
37. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery
38. An economic perspective on policy to reduce antimicrobial resistance
39. National Center for Health Statistics. 1977 summary: National hospital survey